648 related articles for article (PubMed ID: 24129113)
1. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
[No Abstract] [Full Text] [Related]
2. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.
Book SW; Myrick H; Malcolm R; Strain EC
Am J Psychiatry; 2007 Jun; 164(6):979. PubMed ID: 17541066
[No Abstract] [Full Text] [Related]
3. The diverse clinical uses of opioid receptor drugs.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 May; 48(5):11-4. PubMed ID: 20415289
[TBL] [Abstract][Full Text] [Related]
4. Use and misuse of opioid replacement therapies: a Queensland study.
Smirnov A; Kemp R
Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
[TBL] [Abstract][Full Text] [Related]
5. Tramadol dependence: treatment with buprenorphine/naloxone.
Ritvo JI; Koonce R; Thurstone CC; Causey HL
Am J Addict; 2007; 16(1):67-8. PubMed ID: 17364425
[No Abstract] [Full Text] [Related]
6. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
Balhara YP
J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
[No Abstract] [Full Text] [Related]
7. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.
Strain EC; Stoller K; Walsh SL; Bigelow GE
Psychopharmacology (Berl); 2000 Mar; 148(4):374-83. PubMed ID: 10928310
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
Webster L; Hjelmström P; Sumner M; Gunderson EW
J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
10. New pharmacological tool approved for opioid addiction.
Sansovich D
HIV Clin; 2004; 16(3):9-11. PubMed ID: 15366107
[No Abstract] [Full Text] [Related]
11. Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?
Curtiss FR
J Manag Care Pharm; 2008 Mar; 14(2):195-7. PubMed ID: 18331121
[No Abstract] [Full Text] [Related]
12. Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence.
Clay E; Khemiri A; Zah V; Aballéa S; Ruby J; Asche CV
J Med Econ; 2014 Sep; 17(9):626-36. PubMed ID: 24841329
[TBL] [Abstract][Full Text] [Related]
13. Urine Spiking in a Pain Medicine Clinic: An Attempt to Simulate Adherence.
Lee D; Bazydlo LA; Reisfield GM; Goldberger BA
Pain Med; 2015 Jul; 16(7):1449-51. PubMed ID: 25522892
[No Abstract] [Full Text] [Related]
14. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
Mammen K; Bell J
Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Curcio F; Franco T; Topa M; Baldassarre C;
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
[TBL] [Abstract][Full Text] [Related]
16. Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone.
Varghese SP; Kumari P; Wijegunaratne H; Yovankin T; Garlapati V; Koola MM
Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31274259
[No Abstract] [Full Text] [Related]
17. Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update.
Soyka M
Expert Opin Drug Deliv; 2015 Feb; 12(2):339-47. PubMed ID: 25156759
[TBL] [Abstract][Full Text] [Related]
18. Modeling longitudinal changes in buprenorphine treatment outcome for opioid dependence.
Saleh MI
Pharmacopsychiatry; 2014 Nov; 47(7):251-8. PubMed ID: 25321188
[TBL] [Abstract][Full Text] [Related]
19. Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.
McCormick Z; Chu SK; Chang-Chien GC; Joseph P
Pain Med; 2013 Aug; 14(8):1187-91. PubMed ID: 23647815
[TBL] [Abstract][Full Text] [Related]
20. Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment.
Raheemullah A; Lembke A
JAMA Intern Med; 2019 Mar; 179(3):427-428. PubMed ID: 30640372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
